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RECOMBINANT CYCLODEXTRAN 
GLUCANOTRANSFERASE MUTANTS 
This application claims the bene?t of US. Provisional 
Application No. 60/002,110, ?led on Aug. 10, 1995. 
BACKGROUND OF THE INVENTION 
Cyclodextrin glucanotransferase (CGTase) is an industri 
ally important enZyme Which produces cyclodextrins (CDs) 
from starch. Cyclodextrins are cyclic oligosaccharides 
Which consist of six, seven, or eight ot-1,4-linked 
D-glucopyranosyl residues. Schmid, G., “Cyclodextrin gly 
cosyltransferase production: yield enhancement by overex 
pression of cloned genes”, TIBTECH, 7, 244—248 (1989). 
CGTase produces cyclodextrins from starch by an intramo 
lecular transglycosylation reaction. Besides the cycliZation 
reaction, CGTase also catalyZes hydrolytic and intermolecu 
lar transglycosylation reactions. Kitahata, S. in “Handbook 
of amylases and related enzymes: Their sources, isolation 
methods, properties and applications”; (The amylase 
research society of Japan, Ed.); Pergamon Press, Oxford, 
England; 154—164 (1988). The three-dimensional structure 
of CGTase from Bacillus circulans has revealed that the 
protein consists of ?ve globular domains, A, B, C, D, and E. 
Hofmann, B. E., Bender, H. and SchulZ, G. E., “Three 
dimensional structure of cyclodextrin glycosyltransferase 
from Baciullus circulans at 3.4 A resolution”, J. Mol. Biol. 
209, 793—800 (1989). Domain E shares 60% amino acid 
similarity With the raW-starch-binding domain of glucoamy 
lase I and is assumed to be important for the cycliZation 
reaction. Svensson, B., Jespersen, H., Sierks, M. R. & 
Macgregor, A., “Sequence homology betWeen putative raW 
starch binding domains from different starch-degrading 
enZymes”, Biochem. J. 264, 309—311 (1989). Previous 
attempts to shoW the participation of domain E in the 
cycliZation and/or hydrolysis of starch by using C-terminal 
deletions and chimeric constructs of CGTases produced 
contradictory results. Kimura, K., Kataoka, S., Nakamura, 
A., Takano, T., Kobayashi, S., & Yamane, K., “Functions of 
the COOH-terminal region of cyclodextrin glucanotrans 
ferase of alkalophilic Bacillus sp. #1011: relation to cata 
lyZing activity and pH stability”, Biochem. Biophys. Res. 
Comm. 161(3), 1273—1279 (1989). Hellman, J ., Wahlberg, 
M., Karp, M., Korpela, T., & Mantsala, P., “Effects of 
modi?cations at the C-terminus of cyclomaltodextrin glu 
canotransferase from Baciullus circulans var. alkalophilus 
on catalytic activity”, Biotechnol. Appl. Biochem., 12, 
387—396 (1990). Bender, H., “Studies of the mechanism of 
the cycliZation reaction catalyZed by the Wild type and a 
truncated ot-cyclodextrin glycosyltransferase from Kleb 
siella pneumoniae strain M5al, and the [3-cyclodextrin gly 
cosyltransferase from Baciullus circulans strain 8”, Carbo 
hydr. Res, 206, 257—267 (1990). Fujiwara, S. et al., 
“CycliZation characteristics of cyclodextrin glucanotrans 
ferase are conferred by the NH 2-terminal region of the 
enZyme”, Appl. Environm. Microbiol, 58(12), 4016—4025 
(1992). Kaneko, T. Kudo, T. & Horikoshi, K., “Comparison 
of CD composition produced by chimeric CGTases”,Agric. 
Biol. Chem., 54(1) 197—201 (1990). 
Thus it is desirable to elucidate the role of domain E on 
the catalytic behavior of CGTase. 
SUMMARY OF THE INVENTION 
The present invention provides an altered cyclodextrin 
glucanotransferase (CGTase) gene Which produces an 
altered cyclodextrin (CD) pro?le. Preferably, the CGTase 
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2 
gene is altered by the insertion of a heterologous amino acid 
sequence betWeen domain D and domain E of the Wild-type 
cyclodextrin glucanotransferase. Preferably, the inserted 
amino acid sequence is , e.g., 6 amino acids long. Most 
preferably, the amino acid sequence is Ala-Ser-Phe-Asn 
Val-Leu (SEQ ID NO: 1). Preferably, the cyclodextrin 
pro?le is altered such that an increased amount of at least 
one cyclodextrin, e.g., ot-cyclodextrin or y-cyclodextrin, is 
produced compared to the Wild-type CGTase. Most 
preferably, the cyclodextrin pro?le is altered such that an 
increased amount of ot-cyclodextrin is produced. 
The invention further provides an isolated and puri?ed 
DNA sequence encoding a recombinant cyclodextrin glu 
canotransferase Which produces an altered cyclodextrin pro 
?le. Preferably, the CGTase gene is altered by the insertion 
of a heterologous amino acid sequence betWeen domain D 
and domain E of the Wild-type. Preferably, the heterologous 
amino acid sequence is Ala-Ser-Phe-Asn-Val-Leu (SEQ ID 
NO: 1). 
Additionally, the invention provides a host cell trans 
formed so as to express the recombinant cyclodextrin glu 
canotransferase of the present invention. 
Also provided is a method of producing an altered or 
recombinant cyclodextrin glucanotransferase. The method 
comprises the steps of introducing a recombinant DNA 
molecule encoding an altered cyclodextrin glucanotrans 
ferase into a population of cells; expressing the DNA 
molecule encoding the cyclodextrin glucanotransferase in 
the population of cells in an amount suf?cient to alloW for 
puri?cation of the cyclodextrin glucanotransferase; and 
recovering said cyclodextrin glucanotransferase from said 
cells. 
Additionally, the present invention provides a method for 
altering the production of cyclodextrins obtained from starch 
upon reaction With cyclodextrin glucanotransferase. The 
method comprises the step of introducing an expression 
cassette comprising a recombinant DNA molecule encoding 
a mutant cyclodextrin glucanotransferase operably linked to 
a promoter functional in a host cell into the host cell Wherein 
the DNA molecule encodes a cyclodextrin glucanotrans 
ferase Which produces an altered cyclodextrin pro?le. 
Preferably, the cyclodextrin pro?le is altered such that an 
increased amount of ot-cyclodextrin or y-cyclodextrin is 
produced compared to the Wild-type CGTase. Most 
preferably, the cyclodextrin pro?le is altered such that an 
increased amount of ot-cyclodextrin is produced. 
Finally, the present invention provides an expression 
cassette comprising a gene encoding a recombinant cyclo 
dextrin glucanotransferase Which produces an altered cyclo 
dextrin pro?le operably linked to a promoter functional in a 
host cell. Preferably, the cyclodextrin glucanotransferase 
and said promoter sequences are under the transcriptional 
and translational regulatory control of regulatory regions 
functional in a host cell. Furthermore, the expression cas 
sette can be used in a method of introducing an exogenous 
recombinant cyclodextrin glucanotransferase gene into a 
host cell. The method comprises the steps of ?rst, trans 
forming host cells in vitro With an expression cassette 
comprising a DNA molecule encoding a mutant cyclodextrin 
glucanotransferase operably linked to a promoter functional 
in the host cell. Secondly, the host cells are expanded in vitro 
and ?nally, the transformed host cells Which express the 
DNA molecule are identi?ed. Preferably, in this aspect of the 
invention, the host cell is selected from the group consisting 
of insect cells, plant cells, prokaryotic cells, diatoms, yeast 
and algae. 
5,804,426 
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As used herein, the term “heterologous” refers to a DNA 
sequence or amino acid sequence that either does not occur 
in the “native” or “Wild-type” gene or Which is present, but 
has been moved out of its “native” or “Wild-type” position. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 is a depiction of the construction of plasmid pHC1. 
FIG. 2 is a depiction of the construction of plasmid pHC2. 
FIG. 3 is a depiction of the construction of plasmid pHC3. 
FIG. 4 is a depiction of the construction of plasmid pHC4. 
FIG. 5 is a schematic representation of CGTase con 
structs. Abbreviations: WT, Wild-type; CGT, cyclodextrin 
glucanotransferase; SBD, starch-binding-domain of glu 
coamylase I. 
FIG. 6 is a depiction of the halos formed by E. coli 
transformants on a starch-plate. Each transformant Was 
plated onto a LB-amp-starch plate (1% starch) and incubated 
overnight at 37° C. After incubation, the plate Was exposed 
to I2 vapor to examine the formation of halos. (A) E. coli 
JM105 carrying pHC1 (Wild-type CGTase); (B) E. coli 
JM105 carrying pHC2 (truncated CGTase); (C) E. coli 
JM105 carrying pHC3 (chimeric CGTase); (D) E. coli 
JM105 carrying pHC4 (modi?ed CGTase). 
FIG. 7(a) depicts the production of ot-, [3-, and y-CDs from 
soluble starch by Wild-type CGTases. 
FIG. 7(b) depicts the production of ot-, [3-, and y-CDs from 
soluble starch by modi?ed CGTases. 
FIG. 8 is a graphical depiction of the degree of total 
cyclodextrin conversion from 5% starch by Wild-type (O) 
and modi?ed CGTases 
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DETAILED DESCRIPTION OF THE 
INVENTION 35 
To elucidate the role of domain E on the catalytic behavior 
of a B. macerans CGTase, three neW constructs have been 
made. The ?rst construct, truncated CGTase, contained no 
domain E. The second construct, chimeric CGTase, con 
tained the raW-starch-binding domain (SBD) of glucoamy 
lase I (GAI) of Aspergillus niger instead of domain E. The 
last construct, modi?ed CGTase, Was made by inserting six 
amino acids in CGTase gene. 
40 
The invention Will be further described by reference to the 
folloWing detailed examples, Wherein E. coli strains JM105 
(Pharmacia), XL1BLUE (Stratagene) and Novablue 
(Novagen) Were used for general DNA manipulation. E. coli 
strain JM105 Was used for the production of cyclodextrin 
glucanotransferase (CGTase). Plasmid pREI contains 2.1 Kb 
glucoamylase I (GAI) gene from A. niger in pBS+ vector 
(Stratagene). Evans, R., Ford, C., Sierks, M., Nikolov, Z. 
and Svensson, B., “Activity and thermal stability of geneti 
cally truncated forms of Aspergillus glucoamylase”, Gene, 
91, 131—134 (1990). Plasmid pLCGT1, containing 2.3 Kb 
CGTase gene of B. macerans in pCRII vector (Invitrogen), 
Was obtained from Dr. B. Tao of Purdue University. The 
sequence of CGTase gene Was described by Takano et al., 
“Molecular cloning, DNA nucleotide sequencing, and 
expression in Bacillus subtilis cells of the Bacillus macerans 
cyclodextrin glucanotransferase gene”,J. Bacterial, 166(3), 
1118—1122 (1986). The pT7Blue T-vector for cloning of 
PCR products Was purchased from Novagen. The pKK223-3 
vector for overexpression of CGTase in E. coli Was pur 
chased from Pharmacia. 
55 
65 
General DNA manipulation Was done by the standard 
methods described in Maniatis et al., “Molecular Cloning: A 
4 
Laboratory Manual”, Cold Spring Harbor Laboratory, NeW 
York, 1989. E. coli Was transformed using CaCl2 or elec 
troporation according to Aubusel et al., Current protocols in 
molecular biology, 1987. Small and large scale plasmid 
preparations Were performed using WiZard Minipreps and 
Qiagen-tip purchased from Promega and Qiagen. Restriction 
endonuclease, ligase and Taq polymerase Were purchased 
from Promega. Alkaline phosphatase and KlenoW fragment 
Were purchased from Pharmacia, Whereas Geneclean kit Was 
purchased from Bio101. 
The LB-amp plate (75 pig/ml ampicillin, 1.5% agar, 1% 
trypton, 0.5% yeast extract, and 0.5 % NaCl, pH7_2) Was used 
for the selection of E. coli transformants. The X-gal-IPTG 
plate (LB agar plates containing 50 pig/ml ampicillin, 15 
pig/ml tetracycline, 70 pig/ml X-gal, and 80 pM IPTG) Was 
used for screening of PCR recombinants. The LB-amp 
starch plate (LB-amp agar plates containing 1% soluble 
starch) Was used for plate-enZyme assays to detect the 
starch-hydrolyZing activity of CGTase. LB-amp medium 
Was used to cultivate E. coli cells for enZyme puri?cation. 
EXAMPLE 1 
Construction and manipulation of CGTase genes 
To construct a plasmid for overexpression of B. macerans 
CGTase gene in E. coli, an EcoRI DNA fragment (2.28 kb) 
containing CGTase gene from plasmid pLCGT1 Was sub 
cloned into pKK223-3 to form plasmid pHC1 (FIG. 1). To 
construct CGTase With deletion of domain E (Thr584 
Asn687), a universal primer and a 41-mer Were used to 
amplify the CGTase gene in pLCGT1 by polymerase chain 
reaction (PCR). The primers Were synthesiZed by Nucleic 
Acid Facility of IoWa State University and DNA Interna 
tional Inc.. The universal primer Was S‘GTAAAACGACG 
GCCAGT 3‘(SEQ ID NO: 2); the 41-mer primer Was 
5‘GAGCTCCCGGGTTAGCTAGCCAGTACAT 
TGAAGCTTTTGAA3‘(SEQ ID NO: 3). The 41-mer primer 
matches the DNA sequence encoding the region betWeen 
domains D and E of CGTase (Phe577-Leu583). Therefore, 
the PCR product Was about 2.0 kb and encoded domains A 
through D. Due to the design of the 41-mer primer sequence, 
a NheI restriction site, a stop codon and a SmaI restriction 
site Were generated at the 3‘ end (corresponding to Leu583) 
of the PCR fragment. The 2.0 kb PCR fragment Was then 
cloned into pT7Blue T-vector (Novagen), and designated as 
pHCT. To create an expression plasmid for truncated 
CGTase gene, plasmid pHC1 DNA Was digested With BstXI 
and SmaI. The large fragment (6.11 kb) containing 
pKK223-3 vector and part of CGTase gene (corresponding 
to Ser1-Ile470) Was ligated With the 0.34 kb BstXI-SmaI 
DNA fragment (corresponding to Thr471-Leu583) of 2.0 kb 
PCR fragment from pHCT to construct plasmid pHC2. The 
plasmid pHC2 contains pKK223-3 vector, part of CGTase 
gene encoding domainsAto D, and NheI site and stop codon 
at the 3‘-end of this truncated CGTase gene (FIG. 2) . The 
NheI site in pHC2 Was used as a convenient restriction site 
for further constructing chimeric and modi?ed CGTases. 
To create a chimeric CGTase, a NheI-PstI fragment (0.5 
kb) from plasmid pREI, containing the sequence of the 
starch-binding-domain of GAI, Was inserted into NheI-PstI 
sites of plasmid pHC2. The resulting plasmid Was named 
pHC3 (FIG. 3). 
A modi?ed CGTase With six-amino-acid insertion 
betWeen domain D and E Was constructed as folloWs. A 0.4 
kb HindIII fragment Was isolated from pHC1 and the 
cohesive ends of this HindIII fragment Were partially ?lled 
in With dGTP and dAT P. The modi?ed 0.4 kb HindlII 
fragment from pHC1 encoded domain E, ?ve amino acids 
5,804,426 
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(Ser579-Leu583) of domain D, and one amino acid (Ala) 
derived from the modi?cation of 5 ‘-end of HindIII fragment. 
Plasmid pHC2 DNA Was digested With NheI and subse 
quently partially ?lled in With dCTP and dTTP to be 
compatible With the above modi?ed HindIII ends. The 
modi?ed pHC1 HindIII fragment Was inserted into the 
modi?ed NheI site of pHC2 to create pHC4 (FIG. 4). 
DNA sequencing Was done by the NAF of ISU to con?rm 
that the DNA sequences of pHC1, pHC2, pHC3 and pHC4 
Were correct. The domain organiZation of CGTase constructs 
are shoWn in FIG. 5. 
EXAMPLE 2 
Production and puri?cation of CGTases 
E. coli JM105 cells containing pHC1, pHC2, pHC3, or 
pHC4 Were groWn in 1 liter of LB-amp medium at 37° C. 
The expression of CGTases Was induced With 0.3 mM IPTG 
added at A600 of 0.6. After the induction, the cells Were 
incubated at 37° C. for 3 hours. Cells Were harvested by 
centrifugation (5,000 xg, for 10 minutes), and then broken in 
tWo passes by a French Press at a pressure of 4,000 psi. The 
soluble crude enZyme Was separated from the cell debris by 
centrifugation (10,000 xg, for 10 minutes). Ammnonium 
sulfate (80% saturation) Was added to the supernatant and 
the solution Was stirred at 4° C. for 1 hour. After centrifu 
gation (16,000 xg, for 30 minutes), the precipitate Was 
dissolved in 10 ml of 20 mM Tris buffer, pH 7.5. The 
enZyme solution Was dialyZed and applied to ot-CD-coupled 
Sepharose 6B column. The various constructs Were eluted 
With 15 mM (X-CD. The af?nity gel Was prepared according 
to the method described by LasZlo at al., “Puri?cation of 
cyclodextrin glycosyltransferase enZyme by af?nity 
chromatography”, Starch/Starke, 33, 281—283 (1981). The 
epoxy-activated Sepharose 6B Was purchased from Pharma 
cia. 
Starch-plate assay Was used to con?rm the expression of 
the Wild-type and engineered CGTases in E. coli. E. coli 
JM105 carrying pHC1, pHC2, pHC3 or pHC4 Was plated on 
a LB-amp-starch plate (1% starch) and incubated overnight 
at 37° C. The formation of halos Was examined by exposing 
the plate to I2 vapor. The halos Which appeared around 
colonies indicate that starch has been degraded by the 
hydrolytic activity of CGTases. E. coli JM105 carrying 
pHC1> Which has the Wild-type CGTase gene, shoWed a large 
halo and served as a positive control (FIG. 6). E. coli JM105 
carrying pHC4, Which has the modi?ed CGTase gene, also 
formed a large halo. These results indicated that the Wild 
type and modi?ed CGTases Were produced in E. coli and had 
the starch-hydroliZing activity. 
No halos Were detected around the colonies of E. coli 
JM105 carrying pHC2 or pHC3, indicating that no active 
truncated CGTase (pHC2) and chimeric CGTase (pHC3) 
Were produced in E. coli. 
Wild-type CGTase, truncated CGTase, chimeric CGTase 
and modi?ed CGTase Were puri?ed from E. coli as 
described above. Puri?ed Wild-type CGTase shoWed a single 
band (74 kDa) on the SDS-PAGE and Western blot. Modi 
?ed CGTase shoWed one major band of 74 kDa and several 
bands With molecular Weights betWeen 40—50 kDa (data not 
shoWn). The chimeric CGTase Was puri?ed and the exist 
ence of the starch-binding-domain (SBD) of GAI Was con 
?rmed by Western blotting using anti-glucoamylase I. A 
proteolytic degradation Was also observed for chimeric 
CGTase. The puri?cation and subsequent detection of trun 
cated CGTase Was unsuccessful. 
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EXAMPLE 3 
Analytical assays 
ot-CD activity of CGTase Was assayed by using the 
methylorange method described by Lejeune et al., “A spec 
trophotometric assay for the cycliZation activity of cyclo 
maltohexaose (ot-cyclodextrin) glucanotransferase”,Analyt. 
Biochem, 181, 6—11 (1989). The enZyme reaction Was 
performed at 40° C. The reaction mixture contained 1% 
soluble starch, 35 pM methylorange in 50 mM phosphate 
buffer, pH 6.0. To stop the reaction, 6M HCl Was added to 
a ?nal concentration of 0.3M. The reaction solution Was 
incubated at 16° C. for 30 min, and the absorbance at 505 nm 
Was measured. One unit of cycliZation activity is de?ned as 
the amount of enZyme that catalyZes the formation of 1 
pmole ot-CD per minute under the assay conditions. 
The speci?c activity of the modi?ed CGTase Was reduced 
to 3.3% of that of the Wild-type CGTase (Table 1). The 
cycliZation and hydrolytic activities of the truncated CGTase 
Were not detectable. The chimeric CGTase shoWed no 
cycliZation activity and very Weak hydrolytic activity, Which 
Was difficult to quantify. The latter results suggest that the 
domain E of CGTase is important for cycliZation activity. 
The attachment of SBD to the C-terminus of truncated 
CGTase did not produce CD-functional enZyme. 
TABLE 1 
OL-CD speci?c activity of Wild-type and engineered CGTases. 
Enzyme Speci?c activity (U/mg) 
WT-CGT 
Truncated CGT not detectable 
Chimeric CGT not detectable 
Modi?ed CGT 7 
211 
The amounts of ot-, [3-, and y-CDs produced from soluble 
starch by Wild-type and modi?ed CGTases Were assayed by 
HPLC. Speci?cally, a reaction mixture (pH 6.0) containing 
5% soluble starch, 3 mM CaCl2, and 50 mM phosphate 
buffer Was incubated With 0.9 U of each the Wild type and 
the modi?ed CGTase in a total volume of 5 ml at 40° C. 
Samples Were WithdraWn and heated in a boiling Water bath 
for 10 minutes to stop the reaction. The concentration of ot-, 
[3-, and y-CD in the reaction mixture Was measured by HPLC 
on a Spherisorb-NH2 column (Phase Separations Inc, 
NorWalk, Conn.) equipped With a RI detector (Erma RI 
detector, ERC-7512, Erma Inc). The mobile phase Was 65% 
aqueous acetonitrile at a How rate of 1 ml/min. 
Time course of CD production by CGTases is shoWn in 
FIG. 7. Wild-type CGTase produced mainly ot-CD at the 
initial stage of the reaction (FIG. 7A). The ot-CD production 
gradually decreased With the progression of the reaction. 
The amount of [3-CD increased With the increase of the 
reaction time. The product pro?le of modi?ed CGTase 
shoWed signi?cant difference from Wild-type CGTase (FIG. 
7B). The modi?ed CGTase produced signi?cantly loWer 
amounts of [3- and y-CDs than the native enZyme, While 
maintaining the same level of ot-CD production. The pro 
ductivities of [3-CD and y-CD Were loW, and did not change 
even after prolonged incubation. These results indicate that 
the special modi?cation of CGTase changed the product 
pro?le of the enZyme. 
The degree of total CD conversion from 5% starch is 
shoWn in FIG. 8. The modi?ed CGTase has loWer conver 
sion compared to Wild-type CGTase mainly due to the 
reduced [3-CD production. 
The protein concentration Was determined using the Bio 
Rad protein assay. Sodium dodecyl sulfate (SDS) 
5,804,426 
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polyacrylamide gel electrophoresis (PAGE) Was performed 
on 8.5% gels and protein bands Were stained with C00 
massie Brilliant blue. The Western blot Was performed by 
transferring the proteins from the SDS-PAGE gels to a 
nitrocellulose membrane With a Transblot SD semidry 
blotter (Bio-Rad). Polyclonal antibodies against CGTase 
Were used to detect the presence of CGTases. 
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4. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 2 Wherein the cyclodeXtrin pro?le is altered 
such that an increased amount of y-cyclodeXtrin is produced 
compared to the Wild-type cyclodeXtrin glucanotransferase. 
5. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 1 Wherein the heterologous amino acid 
sequence comprises SEQ ID NO: 1. 
SEQUENCE LISTING 
( 1 ) GENERAL INFORMATION: 
( i i i )NUMBER OF SEQUENCES: 3 
( 2 ) INFORMATION FOR SEQ ID NO:1: 
( i )SEQUENCE CHARACTERISTICS: 
( A ) LENGTH: 6 amino acids 
( B )TYPE: amino acid 
( c )STRANDEDNESS: single 
( D )TOPOLOGY: linear 
( i i ) MOLECULE TYPE: peptide 
( v ) FRAGIVEENT TYPE: internal 
( X i ) SEQUENCE DESCRIPTION: SEQ ID NO:1: 
Ser Phe Asn Val 
1 5 
Leu 
( 2 ) INFORMATION FOR SEQ ID NO:2: 
( i )SEQUENCE CHARACTERISTICS: 
( A ) LENGTH: 17 base pairs 
( B ) TYPE: nucleic acid 
( c )STRANDEDNESS: single 
( D )TOPOLOGY: linear 
( i i ) MOLECULE TYPE: Genomic DNA 
( X i ) SEQUENCE DESCRIPTION: SEQ ID NO:2: 
GTAAAACGAC GGCCAGT 
( 2 ) INFORMATION FOR SEQ ID NO:3: 
( i )SEQUENCE CHARACTERISTICS: 
( A ) LENGTH: 41 base pairs 
( B ) TYPE: nucleic acid 
( c )STRANDEDNESS: single 
( D )TOPOLOGY: linear 
( i i ) MOLECULE TYPE: Genomic DNA 
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:3: 
GAGCTCCCGG GTTAGCTAGC CAGTACATTG AAGCTTTTGA A 
17 
41 
What is claimed is: 
1. An recombinant altered Wild-type cyclodeXtrin glucan 
otransferase comprising a heterologous amino acid sequence 
inserted betWeen domain D and domain E. 
2. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 1 Wherein the cyclodeXtrin pro?le is altered 
such that an increased amount of at least one cyclodeXtrin is 
produced compared to the Wild-type cyclodeXtrin glucan 
otransferase. 
3. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 2 Wherein the cyclodeXtrin pro?le is altered 
such that an increased amount of ot-cyclodextrin is produced 
compared to the Wild-type cyclodeXtrin glucanotransferase. 
55 
65 
6. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 1 Wherein the cyclodeXtrin pro?le is altered 
such that a decreased amount of [3- and y-cyclodeXtrin is 
produced compared to the Wild-type cyclodeXtrin glucan 
otransferase. 
7. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 1 Wherein the cyclodeXtrin pro?le is altered 
such that an increased amount of at least one cyclodeXtrin is 
produced compared to the Wild-type cyclodeXtrin 
glucanotransferase, and Wherein the cyclodeXtrin pro?le is 
altered such that a decreased amount of [3- and 
y-cyclodeXtrin is produced compared to the Wild-type cyclo 
deXtrin glucanotransferase. 
5,804,426 
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8. The recombinant altered cyclodeXtrin glucanotrans 
ferase of claim 7 wherein the cyclodeXtrin pro?le is altered 
such that an increased amount of ot-cyclodextrin is produced 
compared to the Wild-type cyclodeXtrin glucanotransferase 
and Wherein the cyclodeXtrin pro?le is altered such that a 
10 
decreased amount of [3-cyclodeXtrin is produced compared 
to the Wild-type cyclodeXtrin glucanotransferase. 
